ORAGENICS INC Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oragenics Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Oragenics Inc Return On Equity for the quarter ending June 30, 2024 was -573 %, a 447% decline year-over-year.
  • Oragenics Inc annual Return On Equity for 2023 was -304 %, a 267% decline from 2022.
  • Oragenics Inc annual Return On Equity for 2022 was -82.9 %, a 63.3% decline from 2021.
  • Oragenics Inc annual Return On Equity for 2021 was -50.8 %, a 76.9% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -573 -468 -447% Apr 1, 2024 Jun 30, 2024
Q1 2024 -415 -327 -373% Jan 1, 2024 Mar 31, 2024
Q4 2023 -304 -221 -267% Oct 1, 2023 Dec 31, 2023
Q3 2023 -110 -40.1 -57.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -105 -42.8 -68.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -87.7 -32.7 -59.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -82.9 -32.1 -63.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -69.6 -7.15 -11.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -62.1 +13.2 +17.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -55 +93.4 +63% Jan 1, 2022 Mar 31, 2022
Q4 2021 -50.8 +169 +76.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -62.5 +149 +70.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -75.3 +91.8 +54.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -148 -55.9 -60.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -219 -151 -223% Oct 1, 2020 Dec 31, 2020
Q3 2020 -211 -149 -241% Jul 1, 2020 Sep 30, 2020
Q2 2020 -167 -105 -171% Apr 1, 2020 Jun 30, 2020
Q1 2020 -92.5 -26.7 -40.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -68 +24.6 +26.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -61.8 +60.2 +49.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 -61.7 +146 +70.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 -65.8 +160 +70.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -92.6 +206 +69% Oct 1, 2018 Dec 31, 2018
Q3 2018 -122 +439 +78.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -207 +136 +39.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -226 -26.3 -13.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -299 -118 -65.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -561 -409 -270% Jul 1, 2017 Sep 30, 2017
Q2 2017 -343 -163 -90.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -200 +209 +51.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -180 +73.2 +28.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -151 +26.6 +14.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -180 -64.3 -55.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 -409 -359 -720% Jan 1, 2016 Mar 31, 2016
Q4 2015 -253 -206 -433% Oct 1, 2015 Dec 31, 2015
Q3 2015 -178 -121 -215% Jul 1, 2015 Sep 30, 2015
Q2 2015 -116 +20 +14.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -49.9 +111 +69% Jan 1, 2015 Mar 31, 2015
Q4 2014 -47.6 +144 +75.2% Oct 1, 2014 Dec 31, 2014
Q3 2014 -56.5 +166 +74.6% Jul 1, 2014 Sep 30, 2014
Q2 2014 -136 -37.5 -38.1% Apr 1, 2014 Jun 30, 2014
Q1 2014 -161 +38.1 +19.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -192 +23.8 +11% Oct 1, 2013 Dec 31, 2013
Q3 2013 -223 +4.19K +95% Jul 1, 2013 Sep 30, 2013
Q2 2013 -98.3 -318 -145% Apr 1, 2013 Jun 30, 2013
Q1 2013 -199 -289 -322% Jan 1, 2013 Mar 31, 2013
Q4 2012 -215 Oct 1, 2012 Dec 31, 2012
Q3 2012 -4.41K Jul 1, 2012 Sep 30, 2012
Q2 2012 219 Apr 1, 2012 Jun 30, 2012
Q1 2012 89.8 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.